Page 188 - Aet News Today

The power of digital health in helping people manage pain is clear, yet it remains untapped potential. All the players, from digital health vendors to payers and providers, need to work together to make it a scalable reality.

The Journey recently launched as a Phoenix-based venture studio designed to create new healthcare startups with diverse founders. The studio works with entrepreneurs from underrepresented backgrounds across the country, helping them prototype, scale and commercialize digital health platforms.

MedCity News is launching a new podcast called MedCity Moves focusing on healthcare's corporate ladder. Published monthly, episodes will provide a summary of notable executive appointments and layoff news — as well as an interview with a recently-appointed healthcare leader or anyone that is experiencing a shift in their job.

After adopting Qventus’ perioperative solution, Allina Health has seen significant gains in surgical case volume and operating room efficiency in just a few months of using the software. The health system's vice president of surgical services and orthopedics recommended that other health systems adopt automation technology. He said the ROI was clear, but the health system declined to provide actual dollar figures.

Allurion Technologies has developed a gastric balloon that does not require surgery. The merger deal taking Allurion public comes as the company continues global commercialization of its technology.

A Michigan Medicine study found that rural residents had higher rates of uninsurance before, during and after pregnancy than urban residents. There were also significant disparities among Hispanic and Indigenous populations, the study found.

Fort Health, a new startup built at Redesign Health, recently launched as a provider of mental healthcare services for children. The company has developed a telehealth-based mental health clinic that partners with pediatricians for referrals and health plans for coverage.

Mineralys Therapeutics upsized its IPO, raising capital to finance clinical trial plans for a molecule that could become an alternative to currently available hypertension medicines. The Mineralys molecule takes a similar approach to a drug candidate that AstraZeneca is acquiring in a $1.3 billion deal.

R&D spending rose in response to Covid-19, bringing with it higher expectations for returns on all biopharma investments. The once sky-high projections are coming down to Earth, with returns now in line with pre-pandemic levels, according to a new Deloitte report.

Suicide-related diagnoses in children and adolescents increased 14% since before the pandemic, a new Evernorth analysis shows. Female and Asian/Pacific Islander youth are especially struggling.